Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001033791 | SCV001197098 | pathogenic | Epilepsy, childhood absence, susceptibility to, 1; Epilepsy, childhood absence, susceptibility to, 5 | 2019-10-14 | criteria provided, single submitter | clinical testing | A gross deletion of the genomic region encompassing the full coding sequence of the GABRB3 gene has been identified. The boundaries of this event are unknown as the deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. Gross deletions of the GABRB3 gene have been previously described in individuals affected with Angelman syndrome (PMID: 11198279). In each of these cases, however, the deletion event also spanned the entire coding sequence of the UBE3A gene. ClinVar contains an entry for a similar variant (Variation ID: 238187). Loss-of-function variants in GABRB3 are known to be pathogenic (PMID: 26950270, 28053010). For these reasons, this variant has been classified as Pathogenic. |